These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22959037)

  • 1. Preface: National Cancer Act.
    Smalley KS
    Adv Pharmacol; 2012; 65():xi-xiii. PubMed ID: 22959037
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeted therapy: overcoming drug resistance with clinical cancer genome.
    Ziogas DE; Katsios CS; Tzaphlidou M; Roukos DH
    Expert Rev Anticancer Ther; 2012 Jul; 12(7):861-4. PubMed ID: 22845399
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer and natural selection.
    Fillon M
    J Natl Cancer Inst; 2012 Dec; 104(23):1773-4. PubMed ID: 23213180
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemotherapy for malignant tumors: problems and prospects].
    Orlova RV; Vaizyan RI; Ivanova AK; Tikhonova EK; Zorina EY
    Vopr Onkol; 2015; 61(2):244-51. PubMed ID: 26087606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The search for optimal response prediction in cancer leads to a personalized approach.
    Van Cutsem E; Ciardiello F
    Target Oncol; 2010 Mar; 5(1):3-4. PubMed ID: 20349283
    [No Abstract]   [Full Text] [Related]  

  • 6. Combining targeted drugs to stop resistant tumors.
    Kaiser J
    Science; 2011 Mar; 331(6024):1542-5. PubMed ID: 21436437
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of genomics on personalized cancer medicine.
    Arteaga CL; Baselga J
    Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized-medicine trials on the rise.
    Benowitz S
    J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496
    [No Abstract]   [Full Text] [Related]  

  • 9. Array-based pharmacogenomics of molecular-targeted therapies in oncology.
    Sanoudou D; Mountzios G; Arvanitis DA; Pectasides D
    Pharmacogenomics J; 2012 Jun; 12(3):185-96. PubMed ID: 22249357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disrupting cancer cells' biocircuits with interactome-based drugs: is 'clinical' innovation realistic?
    Roukos DH
    Expert Rev Proteomics; 2012 Aug; 9(4):349-53. PubMed ID: 22967071
    [No Abstract]   [Full Text] [Related]  

  • 11. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NCI-MATCH launch highlights new trial design in precision-medicine era.
    McNeil C
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142446
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecularly targeted cancer therapy: some lessons from the past decade.
    Huang M; Shen A; Ding J; Geng M
    Trends Pharmacol Sci; 2014 Jan; 35(1):41-50. PubMed ID: 24361003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapidly growing number of therapeutics targeting tumor cell-intrinsic and -extrinsic processes is under development for individualized treatment of cancer patients.
    Giske CG; Jonkers J
    Drug Resist Updat; 2012; 15(1-2):1. PubMed ID: 22326647
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic determinants of anticancer drug activity: towards a global approach to personalized cancer medicine.
    Picker A; Jackson DB
    Expert Rev Mol Diagn; 2011 Jul; 11(6):567-77. PubMed ID: 21745011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional drug-gene interactions in lung cancer.
    Smida M; Nijman SM
    Expert Rev Mol Diagn; 2012 Apr; 12(3):291-302. PubMed ID: 22468819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Targeted therapy of a cancer patient is multiprofessional collaboration].
    Ristimäki A; Kytölä S; Haglund C; Bono P
    Duodecim; 2013; 129(10):1071-9. PubMed ID: 23767137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calculated resistance in cancer.
    Sawyers CL
    Nat Med; 2005 Aug; 11(8):824-5. PubMed ID: 16079872
    [No Abstract]   [Full Text] [Related]  

  • 19. Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1.
    Gillet JP; Gottesman MM
    Drug Resist Updat; 2012; 15(1-2):2-4. PubMed ID: 22465109
    [No Abstract]   [Full Text] [Related]  

  • 20. Biospecimen banking: the pathway to personalized medicine for patients with cancer.
    Scolyer RA; Thompson JF
    J Surg Oncol; 2013 Jun; 107(7):681-2. PubMed ID: 23280671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.